Danaher Corporation (NYSE:DHR) is one of the best long term stocks to buy according to hedge funds. On June 10, Danaher completed its acquisition of Masimo Corporation, a specialist in pulse oximetry ...

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring solutions, today announced FDA 510(k) clearance for an opioid-induced ...

This clearance represents the first implementation of Masimo’s OIRD detection capability in a hospital monitoring solution. By combining the trusted signal quality of best-in-class Masimo SET ® with ...

June 8, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor. The Nell-EQ™ ...

Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced ...

NICU Study Adds to the Evidence Demonstrating SET®’s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation Categories or Race ...

Masimo’s long-time lawsuit over Apple Watch patent infringement has encountered another setback, as a U.S. District Court filing reveals the complaint against the USITC will be dismissed with ...

Apple has been embroiled in a six-year legal battle over one of its Apple Watch health apps. The end may finally be in sight, and here's what Apple has to say about it. Anna Gragert Senior Editor, ...

NYSE:MS: $24.27 million (15.6% of AUM) NASDAQ:AMZN: $15.30 million (9.8% of AUM) NYSE:TEVA: $11.47 million (7.4% of AUM) NYSE:NKE: $11.45 million (7.4% of AUM) NYSE:ALC: $8.53 million (5.5% of AUM) As ...

What just happened? Apple's latest Apple Watch redesign has cleared a key hurdle at a US trade agency, easing one immediate threat to its wearable roadmap while leaving a broader, high-stakes patent ...